- Home
- MAGN vs SAGE Comparison
MAGN vs SAGE Comparison
Compare MAGN & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAGN
- SAGE
- Stock Information
- Founded
- MAGN 1864
- SAGE 2010
- Country
- MAGN United States
- SAGE United States
- Employees
- MAGN N/A
- SAGE N/A
- Industry
- MAGN Paper
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- MAGN Basic Materials
- SAGE Health Care
- Exchange
- MAGN Nasdaq
- SAGE Nasdaq
- Market Cap
- MAGN 455.0M
- SAGE 413.9M
- IPO Year
- MAGN N/A
- SAGE 2014
- Fundamental
- Price
- MAGN $12.42
- SAGE $6.53
- Analyst Decision
- MAGN Hold
- SAGE Hold
- Analyst Count
- MAGN 1
- SAGE 19
- Target Price
- MAGN $16.00
- SAGE $9.88
- AVG Volume (30 Days)
- MAGN 818.5K
- SAGE 784.7K
- Earning Date
- MAGN 05-07-2025
- SAGE 04-29-2025
- Dividend Yield
- MAGN N/A
- SAGE N/A
- EPS Growth
- MAGN N/A
- SAGE N/A
- EPS
- MAGN N/A
- SAGE N/A
- Revenue
- MAGN $2,636,000,000.00
- SAGE $47,404,000.00
- Revenue This Year
- MAGN $47.87
- SAGE $103.73
- Revenue Next Year
- MAGN $4.76
- SAGE $41.15
- P/E Ratio
- MAGN N/A
- SAGE N/A
- Revenue Growth
- MAGN 15.87
- SAGE N/A
- 52 Week Low
- MAGN $11.43
- SAGE $4.62
- 52 Week High
- MAGN $26.78
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- MAGN N/A
- SAGE 41.63
- Support Level
- MAGN N/A
- SAGE $6.35
- Resistance Level
- MAGN N/A
- SAGE $6.78
- Average True Range (ATR)
- MAGN 0.00
- SAGE 0.24
- MACD
- MAGN 0.00
- SAGE 0.00
- Stochastic Oscillator
- MAGN 0.00
- SAGE 20.00
About MAGN Magnera Corporation Common Stock
Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.